Sanjivani Paranteral Ltd. benchmarking: Perfomance to industry peers

Financial

	Sanjivani Paranteral	Ambalal Sarabhai Ent	BDH Inds
Operational Metrics
Pharmaceuticals
Quarterly Sales Volume - Injectables	n/a	n/a	n/a
Quarterly Sales Volume - Orals	n/a	n/a	n/a
Quarterly Sales Volume - Nutraceuticals	n/a	n/a	n/a
Financials
5 yr Average ROE	-34.5 %	19.11 %	14.8 %
5yr average Equity Multiplier	-1.07	2.07	1.46
5yr Average Asset Turnover Ratio	1.28	0.75	0.89
5yr Avg Net Profit Margin	11.86 %	10.89 %	11.59 %
Price to Book	4.57	1.44	3.03
P/E	27.5	22.06	21.98
5yr Avg Cash Conversion Cycle	9.84 Days	-37.53 Days	-27.79 Days
Inventory Days	50.77 Days	33.51 Days	31.79 Days
Days Receivable	53.66 Days	63.69 Days	116.74 Days
Days Payable	138.53 Days	147.98 Days	156.43 Days
5yr Average Interest Coverage Ratio	21.37	9.88	78.47
5yr Avg ROCE	-90.78 %	24.01 %	19.81 %
5yr Avg Operating Profit Margin	14.73 %	5.29 %	14.91 %
5 yr average Debt to Equity	-0.19	0.32	0.1
5yr CAGR Net Profit	12.42 %	-30.01 %	7.83 %
5yr Average Return on Assets	15.34 %	8.69 %	10.19 %
Shareholdings
Promoter Holding	31.2 %	31.36 %	49.7 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	3.85 %	0.59 %	0.04 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Sanjivani Paranteral	Ambalal Sarabhai Ent	BDH Inds
Product Wise Break-Up	Product Wise Break-Up Injectables 50.0 Tablets 42.6 Nutraceuticals 7.4 Electronics 0 Pharmaceuticals 0	Product Wise Break-Up Electronics 41.47 Nutraceuticals 0 Pharmaceutical 58.53 Tablets 0 Injectables 0	Product Wise Break-Up Electronics 0 Nutraceuticals 0 Pharmaceuticals 100.0 Tablets 0 Injectables 0
Location Wise Break-Up	Location Wise Break-Up Middle East & Africa 41.2 Latin America 29.4 India 28.0 CIS Countries 1.4 Rest of the World 0	Location Wise Break-Up CIS Countries 0 Rest of the World 35.44 Latin America 0 India 64.56 Middle East & Africa 0	-